Nanox.AI Bone Solutions, Advanced AI-Powered Software for Spine Assessment, Recommended by NICE for Early Value Assessment in UK National Health Service hospitals

Core Insights - Nanox's AI solutions, HealthOST and HealthVCF, have been recommended for use in UK NHS hospitals for three years as part of an evaluation of AI in bone disease detection [1][2][3] - The National Institute for Health and Care Excellence (NICE) has included these solutions in an Early Value Assessment to gather evidence on their effectiveness in detecting vertebral fragility fractures [2][3] - The AI technologies aim to enhance the detection of vertebral fragility fractures through opportunistic detection in X-ray images and CT scans [3] Company Overview - Nanox.AI is a subsidiary of Nanox focused on deep-learning medical imaging analytics, targeting chronic and acute diseases [6] - The company aims to drive the transition to preventive healthcare by providing affordable medical imaging technologies [7] - Nanox's ecosystem includes various components such as Nanox.ARC, Nanox.AI, Nanox.CLOUD, and Nanox.MARKETPLACE, all designed to improve early detection and treatment [8] Product Details - HealthOST and HealthVCF utilize existing CT scans to support early detection of bone diseases without additional imaging or radiation exposure [4] - These solutions are integrated with existing PACS workflows, allowing real-time identification of clinically significant findings [5] - The tools are expected to improve patient outcomes by enabling timely preventive interventions for conditions like osteoporosis [5]